138 related articles for article (PubMed ID: 8977680)
1. Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996.
Berth-Jones J; Voorhees JJ
Br J Dermatol; 1996 Nov; 135(5):775-7. PubMed ID: 8977680
[No Abstract] [Full Text] [Related]
2. A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses.
Bourke JF; Berth-Jones J; Holder J; Graham-Brown RA
Br J Dermatol; 1996 Apr; 134(4):777-9. PubMed ID: 8733391
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine in the treatment of psoriasis.
Gulliver WP
Cutis; 2000 Nov; 66(5):365-9. PubMed ID: 11107522
[TBL] [Abstract][Full Text] [Related]
4. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C
Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin in childhood psoriasis.
Perrett CM; Ilchyshyn A; Berth-Jones J
J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
[TBL] [Abstract][Full Text] [Related]
6. The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: a prospective cohort study.
Chew AL; Bashir SJ; Johnston A; Barker JN; Smith CH
J Dermatolog Treat; 2011 Apr; 22(2):79-85. PubMed ID: 20673153
[TBL] [Abstract][Full Text] [Related]
7. Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin.
Gulliver WP; Murphy GF; Hannaford VA; Primmett DR
Br J Dermatol; 1996 Sep; 135 Suppl 48():35-9. PubMed ID: 8881903
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Bigby M
Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
[No Abstract] [Full Text] [Related]
9. Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels.
Heydendael VM; Spuls PI; Ten Berge IJ; Opmeer BC; Bos JD; de Rie MA
Br J Dermatol; 2002 Jul; 147(1):122-9. PubMed ID: 12100194
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects: preliminary experience with a novel oral formulation of cyclosporin (Neoral).
Berth-Jones J
Br J Dermatol; 1996 Sep; 135 Suppl 48():5-8. PubMed ID: 8881897
[TBL] [Abstract][Full Text] [Related]
11. The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.
Ohtsuka T
Arch Dermatol Res; 2008 Nov; 300(10):545-50. PubMed ID: 18797895
[TBL] [Abstract][Full Text] [Related]
12. The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.
Hakkaart-van Roijen L; Verboom P; Redekop WK; Touw KR; Rutten FF
Pharmacoeconomics; 2001; 19(5 Pt 2):599-608. PubMed ID: 11465304
[TBL] [Abstract][Full Text] [Related]
13. Treatment of psoriasis. Part 2. Systemic therapies.
Lebwohl M; Ali S
J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
[TBL] [Abstract][Full Text] [Related]
14. The use of cyclosporin in a child with generalized pustular psoriasis.
Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
[No Abstract] [Full Text] [Related]
15. Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis.
Erkko P; Granlund H; Remitz A; Rosen K; Mobacken H; Lindelöf B; Reitamo S
Br J Dermatol; 1998 Dec; 139(6):997-1004. PubMed ID: 9990362
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
[TBL] [Abstract][Full Text] [Related]
17. Infant with generalized pustular psoriasis who responded to cyclosporin A therapy.
Takahashi M; Takeuchi M; Matsunaga K
J Dermatol; 2015 Sep; 42(9):911-3. PubMed ID: 26046589
[No Abstract] [Full Text] [Related]
18. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
[TBL] [Abstract][Full Text] [Related]
19. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
Short MW; Vaughan TK
Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate in psoriasis: consensus conference.
Roenigk HH; Auerbach R; Maibach H; Weinstein G; Lebwohl M
J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
[No Abstract] [Full Text] [Related]
[Next] [New Search]
